Introduction
Bovine respiratory syncytial virus (BRSV), a member of the genus Pneumovirus, family Paramyxoviridae, is closely related to human respiratory syncytial virus (HRSV). The RS viruses are the most important cause of lower respiratory tract illness in cattle and young infants (Van der Poel et al., 1994) . In the rearing calf industry, the losses associated with the annual winter outbreaks represent a major economic problem (Verhoeff et al., 1992) .
RSV is an enveloped virus with a negative-sense singlestranded non-segmented RNA genome encoding ten different proteins (McIntosh & Chanock, 1990) : the attachment glycoprotein (G), the fusion protein (F), matrix proteins (M, M2 or Author for correspondence : Jean-Jacques Letesson.
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The EMBL accession numbers of the sequences reported in this paper are as follows : L27802 for isolate RB94 ; U24714 for isolate MVR553 ; U33539 for isolate Lelystad ; U24713 for isolate NMK7 ; U24716 for isolate 85-1330 ; U24715 for isolate Dorset ; and U57823 for isolate BovX. not be correlated with those obtained by the determination of the M r of the F2 polypeptide. Multiple sequence alignments showed a high level of amino acid identity at the inter-subgroup level (85 % identity between subgroup A and subgroup B strains), similar to the intra-subgroup human (H)RSV identity, suggesting that the BRSV isolates form a continuum rather than distinct subgroups. However, unusual variability was observed within the immunodominant domain (amino acids 174-188) in contrast with the situation in HRSV strains belonging to the same subgroup. 22K), the nucleocapsid (N) protein, phosphoprotein (P), the polymerase (L), small hydrophobic (SH) and non-structural proteins [NS1 (1C) and NS2 (1B)].
HRSV isolates have been divided into two subgroups (A and B) based on their reactions with monoclonal antibodies (MAbs) directed against the F and G proteins and the major antigenic difference occurs in the G protein (Mufson et al., 1985 Anderson et al., 1985 ; Gimenez et al., 1986 ; Hendry et al., 1986 ; Walsh et al., 1987 ; Orvell et al., 1987) . In addition, the two subgroups can be distinguished by differences in the apparent size of the F1 and F2 cleavage products and of the P protein as determined by PAGE (Gimenez et al., 1986 ; Norrby et al., 1986 ; Akerlind et al., 1988) .
Antigenic diversity in HRSV is associated with an extensive degree of amino acid sequence heterogeneity. Indeed, between the prototype strains of subgroups A and B there is only 53 % identity between G protein sequences (Johnson et al., 1987) ; within subgroups, the G protein is also highly variable, with 20 % amino acid variability observed between subgroup A strains (Cane et al., 1991) and 9 % amino acid variability between subgroup B strains (Sullender et al., 1991) .
The occurrence of antigenic variation among BRSV isolates was first suggested by Lerch et al. (1989) because polyclonal serum made against one strain of BRSV did not recognize the G protein of another BRSV strain ; furthermore, heterogeneity was reported on the basis of differences in the molecular sizes of some structural proteins, suggesting that BRSV is composed of two distinct subgroups (Baker et al., 1992 ; Mallipeddi & Samal, 1993 b) . Recently, the antigenic heterogeneity of 19 BRSV isolates was investigated through the reactivity of MAbs specific for the G protein in ELISA and in RIPA. Two major (and one intermediate) subgroups were identified, which could also be differentiated on the basis of the M r of the F protein cleavage product, F2 (Furze et al., 1994) .
A molecular analysis of BRSV diversity was initiated by cloning and sequencing the G gene. Sequence data showed a high degree of conservation, with 90-97 % identity in nucleotide sequences and 84-95 % identity in protein sequences .
However, up to now, there have been no studies which establish a direct comparison between the antigenic heterogeneity observed amongst BRSV strains and a molecular analysis of these isolates. Here, we report the reactivity of MAbs directed against the BRSV G protein on eight strains of BRSV and use these results to classify the isolates into two different (and one intermediate) subgroups. We cloned the G gene of seven of these strains and analysed the nucleotide and deduced amino acid sequences in comparison with published G sequences. Our results indicate that, although antigenic divergence exists among BRSV strains, sequence data show a high percentage identity between and amongst the different subgroups, with inter-subgroup variation in BRSV equivalent to variability observed within subgroups in HRSV.
Methods
Viruses and cells. The BRSV strain RB94 from Belgium was isolated at the INRV (Bruxelles, Belgium) and has been described by Wellemans & Leunen (1975) ; strain MVR553 was isolated in Belgium in 1983 and was kindly provided by G. Wellemans (INRV, Bruxelles, Belgium) . The BRSV strain from the Netherlands (Lelystad isolate) was from J. T. Van Oirschot (ID-DLO, Lelystad, The Netherlands) and has been described by Kimman et al. (1986) . Strain NMK7 from Japan was obtained from Y. Inaba (NIAH, Tokyo) and has been described by Inaba et al. (1970) . Strain 85-1330 was supplied by N. Zygraich (SmithKline Beecham Animal Health) and was isolated in the USA in 1985. Strain FS-1 has been described by Smith et al. (1975) . Strain Dorset was provided by J. W. Jacobs (The Royal Veterinary College, University of London, London, UK) and has been described by Jacobs & Edington (1971) . Strain BovX has been described by Paccaud & Jacquier (1970) .
For all purposes, the virus strains were grown in Vero cells, calf testis cells (CTV) or foetal bovine diploid lung (BFDL) cell monolayers at 37 mC in Dulbecco's minimal Eagle's medium containing 10 % foetal bovine serum (FBS), 2 mM glutamine and antibiotics.
Antibodies. Anti-G bovine MAbs 48, 57 and 70 were kindly provided by G. Taylor (AFRC Institute for Animal Health, Compton, UK) and have been described by Furze et al. (1994) . Characterization of BRSV specific anti-G MAb 20 was performed by reactivity with a G-specific peptide (residues 158-189) as determined by PepScan analysis and in a G-peptide based ELISA (Langedijk et al., 1996 a, b) . Anti-F MAb AK13A2 was produced by immunizing BALB\c mice with the human Long strain and has been described by Matheise et al. (1995) .
Immunofluorescence. Calf testis or BFDL cell monolayers grown in microtitre plates (Nunclon ; Nunc) were infected with the BRSV strains at an m.o.i. of 0n1 TCID &! per cell. When extensive cytopathic effects (CPE) were observed, the cells were fixed in acetone. Mock-infected cells were used as controls. The MAbs were gradually diluted in PBS-0n1% Tween 20 and incubated for 1 h at room temperature. After washing in PBS-0n1 % Tween 20, fluorescein-conjugated goat antibody to mouse Ig (Amersham) was added and incubated for 1 h at room temperature. After another washing step, fluorescence was assessed. The determinations were repeated at least twice.
Immunoperoxidase monolayer assay (IPMA). BFDL cells were grown to confluency on microtitre culture plates and infected with the different RSV strains. When CPE occurred, the growth medium was discarded and the plates were washed in PBS. The plates were dried for 45 min at 37 mC, sealed and stored at k20 mC. The monolayers were fixed with cold 4 % paraformaldehyde for 15 min. After washing the plates twice in PBS, they were preincubated for 45 min at 37 mC with phosphate buffer containing 0n65 M NaCl, 1 mM EDTA, 1 % Tween 80, 5 % horse serum (IPMA buffer). During this preincubation, 0n1 % NaN $ was added to the IPMA buffer. The plates were washed twice and incubated with the different MAbs for 1 h at 37 mC. The plates were washed twice again and then incubated for 45 min at 37 mC with rabbit anti-mouse peroxidase conjugate (Dako P260) at a 1 : 200 dilution. After washing five times, the plates were stained with 3-amino-9-ethylcarbazole (Sigma) using H # O # as substrate. The monoclonals and the secondary antibody were diluted in IPMA buffer.
RIPA. BRSV antigen was prepared by infecting Vero cells at approximately 1 TCID &!
per cell for 24 h. Infected cell monolayers were starved for 1 h without glucose prior to the addition of [$H]glucosamine (50 mCi\ml) (Amersham) for 8 h. After labelling, cells were washed in PBS and disrupted in RIPA buffer (10 mM Tris-HCl, pH 7n2, 0n15 M NaCl, 1 mM PMSF, 1 % Triton X-100, 1 % sodium desoxycholate, 0n1% SDS). Proteins were immunoprecipitated with MAb AK13A2 specific for the F protein coated on anti-mouse IgG-conjugated magnetic beads (Dynal) before SDS-PAGE and autoradiography (Hyperfilm, Amersham). Mock-infected Vero cells were prepared as a control.
Cloning of a complete cDNA of the G gene of strain RB94.
A library of cDNA clones to the BRSV strain RB94 mRNA was constructed in the phage λgt11 (Walravens et al., 1990) . Clones containing the G gene were identified by plaque hybridization using a $#P-labelled oligonucleotide (Eurogentec) made from the sequence of strain 391-2 (Lerch et al., 1990) 
"( ) and containing the start codon ATG (underlined). Positive clones were digested with EcoRI to remove their insert from the λgt11 vector and ligated into plasmid pBluescript (Stratagene) for further subcloning.
RT-PCR.
Total RNA was extracted from virus-infected Vero, CTV or BFDL cells using Ultraspec reagent (Biotecx). Synthesis of the G gene of strains NMK7, 85-1330, Dorset, MVR553, Lelystad and BovX was carried out using the following protocol (L. Le, personal communication) : 5 µg of total RNA was used for the synthesis of first-strand DNA with MMLV reverse transcriptase (Gibco-BRL) at 37 mC for 60 min using one of the oligonucleotides (100 pmol) shown in Table 1 . This DNA was then used in a 100 µl PCR mix with 4 U of DyNAZyme polymerase (Techgen) and 100 pmol of primers (Table 1) which amplify either the full-length or Table 1 . Pairs of PCR primers used for amplification of the G gene of BRSV strains and size of PCR products obtained All primers were designed on the basis of the G sequence of strain RB94 ; the sequence of primer R3O1 was derived from strain BovX and that of primer D3 was derived from previously published G gene sequences (Lerch et al., 1990 ; . Primer F4 hybridizes to the F gene of strain RB94 (Walravens et al., 1990) .
Primer
Sequence 5h-3h * Position indicated in relation to the ATG of the A51908 strain G sequence , except for primer F4 whose position is indicated relative to the ATG of the F gene of strain RB94. † Aspecific priming of G2-2 resulted in amplification of a p300 bp 5h-terminal fragment.
required fragments of the G gene of the BRSV strains. The amplifications involved 36 cycles of denaturation at 95 mC for 1 min, hybridization at the calculated T m (Thein & Wallace, 1986 ) for 1 min, and elongation at 72 mC for 1 min in a Techne PHC-3 thermal cycler (New Brunswick Scientific).
Design of primers. Primers were selected by nucleotide sequence analysis with the program Bestfit of the University of Wisconsin GCG package (Devereux et al., 1984) .
The outer primers, OL5, OL3 and G1, and D2 and G2-2, flanked the upstream and downstream coding region of the G gene, respectively and were designed using the sequence of the G gene of strain RB94.
The inner primers, 34446 and D1, correspond to the six terminal amino acids of the conserved 13 amino acid (164-176) region of the HRSV strains and also contain the two conserved cysteine residues (Johnson et al., 1987) . Primer G4 was designed using the sequence of the G gene of strain RB94. Primer D3 was designed on the basis of sequence comparisons of published G gene sequences (Lerch et al., 1990 ; . Primer R3O1 was designed on the basis of the BovX sequence. Primer F4 was designed on the basis of the sequence of the F gene of strain RB94 (Walravens et al., 1990) .
Cloning and sequencing of PCR products. In the case of the Lelystad G gene, a p300 bp 5h-terminal fragment was generated by RT-PCR using primers G1 and G2-2 (Table 1 ) and cloned at the BamHI and SalI sites of plasmid pGEM-4Z (Promega), resulting in construct G37. Primers G4 and F4 generated a fragment containing the 3h-terminal end of the G gene and the 5h-terminal end of the F gene. The PCR product was cloned at the EcoRI and SmaI sites in vector pGEM4-Z, resulting in construct G4-F4. At least three independent clones were sequenced twice on both strands using a T7 polymerase kit (Pharmacia) with the T7 and SP6 primers.
The G gene of strain MVR553 was isolated as two discrete fragments using amplification with primers OL3 plus D1 and D3 plus D2 (Table 1) . The two PCR products were cloned at the BamHI, and BamHI and EcoRI sites of pBluescript, respectively, and three independent clones of each construct were sequenced twice with the universal and reverse primers.
The complete NMK7 strain G gene was obtained by RT-PCR amplification with primers OL5 plus D2 (Table 1) ; the fragment obtained was cloned at the EcoRI site of pBluescript. At least two independent clones were sequenced twice with the universal and reverse primers.
The nucleotide sequence of the G gene of strain 85-1330 was derived from two independent amplifications. Firstly, using primers OL3 plus D1 (Table 1) , a fragment was cloned at the BamHI site of pBluescript. At least two independent clones were sequenced twice with the universal and reverse primers. Secondly, primers 34446 plus D2 were used in an RT-PCR to amplify the 3h terminus of the G gene ; this fragment was sequenced directly using the Cyclist Exo − Pfu DNA Sequencing System (Stratagene) with primers 34446 and D2.
For the BovX strain, two amplifications were needed to obtain the complete sequence of the G gene. Firstly, amplification using primers OL3 plus R3O1, followed by direct sequencing of the purified PCR product with the Cyclist Exo − Pfu DNA Sequencing System using primers OL3 and 34447 yielded data for the first 600 bp of the gene. Secondly, primers 34446 plus D2 were used to amplify the 3h terminus of the G gene and the resulting fragment was sequenced directly with the Cyclist Exo − Pfu DNA Sequencing System.
In the case of strain Dorset, a 5h-terminal PCR product was generated using primers OL3 plus D1 and sequenced directly with the Cyclist Exo − Pfu DNA Sequencing System using primers OL3, D1 (Table 1) and 34447 ( #*" TGGGAAATGCTAAAGCC $!( ). In addition, a 3h-terminal fragment was produced by RT-PCR using primers D3 plus D2 (Table 1) and cloned at the BamHI and EcoRI sites of pBluescript. At least two independent clones were sequenced twice with the universal and reverse primers.
Sequence analysis. Nucleotide and deduced amino acid sequence manipulations were performed on a VAX computer using the programs Bestfit, Pileup, Distances and GrowTree of the University of Wisconsin GCG package (Devereux et al., 1984) .
Results

Antigenic variation amongst BRSV strains
MAbs 20, 48, 57 and 70 were tested in an indirect immunofluorescence assay and in IPMA for their reactivity to eight bovine RSV isolates : five European strains, two North American strains and one Japanese strain (Fig. 1 ). There were three main patterns of reactivity observed. On the basis of these patterns, three subgroups were identified and designated A, B and A\B, in reference to the nomenclature used by Furze et al. (1994) Reactivity of the Dorset isolate was unique and the strain was not classified in any of the three subgroups. Reactivity was positive with MAb 20 ; reactivity with MAb 48 was inconsistent, depending on the assay used -it was positive in immunofluorescence but only weakly positive (at a 1\10 dilution of the MAb) in IPMA. Moreover, strain Dorset did not react with MAbs 57 and 70 in immunofluorescence and reacted only weakly with MAb 57 (at a 1\10 dilution of the MAb) in IPMA.
Analysis of BRSV isolates by RIPA
Strains representative of each subgroup were analysed by RIPA. Thus, BRSV strains NMK7 (subgroup A), RB94, Lelystad and MVR553 (subgroup A\B), and BovX (subgroup B) were labelled with [$H]glucosamine and cell lysates were precipitated with MAb AK13A2 specific for the F protein. These results (not shown) indicate that, when samples were analysed in reducing conditions, AK13A2 immunoprecipitated two protein bands : one band at 48 kDa and one band either at 23 kDa or 17 kDa. The M r of the F glycoprotein cleavage product F2 differed amongst the various BRSV isolates. Thus, the M r for subgroup A isolate NMK7 was 17 000, whereas the M r for intermediate subgroup A\B isolates RB94, Lelystad and MVR553, and of subgroup B isolate BovX was 23 000. These results are summarized in Fig. 1 . 
Cloning and sequencing of the G gene of BRSV strains
In order to determine the molecular basis for the antigenic variation observed among the BRSV isolates and the classification into subgroups, seven isolates were chosen for a genetic analysis involving the sequencing of the G gene. Strains NMK7 and 85-1330 were selected to represent subgroup A ; strain BovX was the prototype of subgroup B ; and strains RB94, MVR553 and Lelystad belonged to the intermediate subgroup A\B. The atypical strain Dorset was also chosen.
For the cloning of the G gene of strain RB94, a library of cDNA clones established in phage λgt11 was screened as described in Methods. Among the positive plaques identified, three (G24, G25 and G28) were selected for further analysis and sequencing. For the other strains, (NMK7, 85-1330, Dorset, MVR553, Lelystad and BovX), RT-PCR and sequencing were performed as described in Methods.
Nucleotide and protein sequence alignments and comparisons
The G nucleotide sequences of the BRSV isolates studied in this report were aligned with published BRSV G gene sequences -391-2, VC-464, FS-1 and A51908 (Lerch et al., 1990 ; -using the program PileUp in the GCG package. The levels of identity among the different G nucleotide sequences were determined by the program Distances. The results ranged from 100 % to 90n1 %. Strain 391-2 (not antigenically typed in our study), the prototype of the A subgroup (Furze et al., 1994) , showed 96n2 % to 95n2% Fig. 2 . Comparison of the deduced amino acid sequences of the attachment protein G gene of various BRSV isolates. The sequence of subgroup A/B prototype strain RB94 is shown ; for the other strains, only differences relative to RB94 are indicated. The sequence of strain 391-2 is from Lerch et al. (1990) ; the sequences of strains VC-464, FS-1 and A51908 are from . The central region of the ectodomain is delineated ; cysteine residues are shown ($). Sequences not determined due to location of amplification primers are indicated by a dot (.).
identity to other subgroup A strains ; identity was comparable with the subgroup A\B strains (94n8 % to 94n4 %) but it was somewhat lower with subgroup B isolates (90 % to 90n1 %). Very little variability was observed amongst the A\B isolates : strains MVR553 and RB94 were identical in sequence, whereas only two nucleotide differences were noted between RB94 and Lelystad isolates (99n7 % identity).
The BovX strain, prototype of the B subgroup, was most closely related in sequence to the A51908 strain (four nucleotides different, 99n3 % identity), which has not been antigenically typed, except for the position of the stop codon. The ORF of the G gene of strain A51908 was 18 nucleotides longer than those of all of the other strains.
Strain Dorset, whose pattern of reactivity with the MAbs was atypical, was the most closely related to strain VC-464 (98n7 % identity), which has not been antigenically typed.
An alignment of the deduced amino acid sequences of the G protein of the different BRSV isolates is shown in Fig. 2 . It was made with respect to subgroup A\B prototype strain RB94. The percentage identities between the amino acid sequences of the G protein of the various strains were determined and, in all cases, the degree of amino acid identity was less than the nucleotide similarity. The predicted G protein of the strains sequenced was 257 amino acids long, comparable to that of strains 391-2, VC-464, and FS-1, but six amino acids shorter than that of strain A51908 (Mallipeddi & Samal, Fig. 3 . Analysis of the relatedness of BRSV G protein sequences. The tree was drawn with the GrowTree command using the neighbour-joining method (Saitou & Nei, 1987) . The lengths of the vertical branches are proportional to the genetic distance between the strains. The sequence of strain 391-2 is from Lerch et al. (1990) ; the sequences of strains VC-464, FS-1 and A51908 are from .
1993 a). The percentage identities between G proteins ranged from 100 % to 83n7%.
Within subgroup A, amino acid identities ranged from 94n7 % to 92 %. Within subgroup A\B, strains RB94 and MVR553 were identical in sequence ; two amino acids differed (99n2 % identity) between strains RB94 and Lelystad. When the subgroup A prototype strain 391-2 was compared with subgroup A\B strains, identities ranged from 92n3 % to 91n7%. This value dropped to 85n5 % when strain 391-2 was compared with subgroup B strain BovX and A51908. Strain Dorset was most closely related to the untyped VC-464 isolate (99n2% identity). The percentage identities between subgroup A\B and subgroup B ranged from 87n7 % to 87n1%.
The G protein of the BovX strain (subgroup B) was identical (100 %) to the untyped A51908 strain, except that the A51908 sequence was six amino acids longer.
The analysis of the relatedness of the G protein sequences is shown as a dendrogram in Fig. 3 . The dendrogram clusters subgroup A strains FS-1, 85-1330 , 391-2, 85-1330 , VC-464 and Dorset ; subgroup A\B strains are located in a separate cluster ; and subgroup B strain BovX and the untyped A51908 strain are furthest apart.
Discussion
In this paper, a panel of MAbs to the G protein categorized eight BRSV strains into two main (and one intermediate) subgroups, in accordance with results obtained by Furze et al. (1994) . Strain Dorset showed a unique pattern of reactivity and was not classified in any particular subgroup.
Differences in the apparent M r of the F cleavage product F2 were observed. Subgroup A strains 391-2, NMK7, 85-1330 and FS-1 represented the low M r (15 500 to 17 000) F2 protein group ; subgroup A\B (RB94, MVR553 and Lelystad) and subgroup B (BovX) strains represented the high M r (23 000) F2 protein group. Previously, Lerch et al. (1991) showed differences in the electrophoretic mobility of the F0 and F2 proteins between BRSV strain 391-2 and HRSV. Also, Mallipeddi & Samal (1993 b) compared the polypeptides of BRSV strains A51908, FS-1, VC-464 and Md-X, and showed that the extent of glycosylation was responsible for the differences in the electrophoretic mobility of the F0 and F2 proteins. Nucleotide sequence data for strains 391-2 (Lerch et al., 1991) , RB94 (Walravens et al., 1990) and A51908 (Zamora & Samal, 1992) show that the potential N-linked glycosylation site at position 70 is absent in the low M r F2 protein strain 391-2, and present in the high M r F2 protein strains RB94 and A51908. A comparison of the sequence of the F gene of more strains of BRSV will be necessary.
Sequencing of the G gene of representative isolates from each subgroup was undertaken in order to delineate the molecular basis for the antigenic variability observed. An alignment of the nucleotide sequences of the G gene showed a high degree of identity, ranging from 100 % to 90 %. The level of identity among amino acid sequences of the G proteins was 100 % to 83n7 %. When subgroup A prototype strain 391-2 was compared with subgroup A\B strains, amino acid identities were 92n3 % to 91n7 %, but only 85n5 % when it was compared with subgroup B strain BovX.
Analysis of the relatedness of the G protein sequence using a multiple alignment program shows that isolates from subgroup A as well as the untyped VC-464 strain and the Dorset strain cluster together, as do subgroup B strain BovX and the untyped A51908 isolate. Subgroup A\B strains Lelystad and the Belgian isolates, RB94 and MVR553, are also located in a separate cluster.
Subgroups A and A\B were more closely related in protein sequence than subgroups A and B or subgroups A\B and B. These results cannot be correlated with those obtained by the determination of the M r of the F2 polypeptide. The M r of F2 of isolates from subgroup A was approximately 15 500 to 17 000, whereas it was approximately 23 000 in subgroups A\B and B, as previously described by Furze et al. (1994) .
In conclusion, this paper represents the first study linking the antigenic with the molecular variability of the G protein in different BRSV subgroups. This work confirms the antigenic variation of BRSV strains (Furze et al., 1994) , although sequence analysis indicates a high level of identity at the inter-subgroup level (85 % amino acid identity between subgroup A and subgroup B strains), similar to the intra-subgroup HRSV identity, suggesting that the BRSV isolates form a continuum rather than distinct subgroups. Thus, the subgroups could be more appropriately named A1, A2, A3, etc.
In HRSV strains, amino acid comparisons show that the differences are not spread evenly throughout the G protein, and that mutations accumulate mainly in the mucin-like regions of the ectodomain. It has been shown that the 15 residue conserved peptide (amino acids 174 to 188) in the central hydrophobic region of the ectodomain is immunodominant in HRSV (Norrby et al., 1987 ; Akerlind-Stopner et al., 1990) and in BRSV (Langedijk et al., 1996 a, b) and plays a major role in protection (Trudel et al., 1991) . This central region is completely conserved in HRSV subgroups A and B but is divergent between HRSV-A and HRSV-B (Johnson et al., 1987 ; Sullender et al., 1990 Sullender et al., , 1991 Cane et al., 1991) . In contrast, despite the relatively high identity between BRSV G proteins, the central region is variable. This observation suggests a different immunological pressure between HRSV-G and BRSV-G. Molecular epidemiology focussed on the antigenic and genetic variability of the G protein during successive epidemics will be necessary to confirm this hypothesis.
The variability in the central region explains the subgrouping of the relatively identical BRSV strains because all the MAbs used for the antigenic typing in this study, except MAb 70, have been mapped to this region of BRSV-G (J. P. M. Langedijk and others, unpublished results). It has been shown that MAb 20 and bovine polyclonal sera specifically recognize the 174 to 185 amino acid peptide of subgroup A and subgroup A\B strains, but not that of subgroup B strains (Langedijk et al., 1996 b) , which has two mutations (proline residues at positions 180 and 184) that seem to be important for binding. Furze et al. (1994) also observed little antigenic cross-reactivity in the G protein between the two BRSV subgroups using polyclonal hyperimmune sera. In the light of these results, our findings concerning sequence variability of the central region confirm the antigenic variation. At this stage, it will be necessary to characterize the biological significance of strain differences in the field and a clearer picture of the evolutionary lineages will require additional sequence determination of more isolates, including strains within a single epidemic period.
